Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 57316 results
Sort by: relevance publication year
Showing results for ISSN matching 0923-7534

Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts

JOURNAL ARTICLE published May 2011 in Annals of Oncology

Authors: R. Saldova | J.M. Reuben | U.M. Abd Hamid | P.M. Rudd | M. Cristofanilli

https://doi.org/10.1093/annonc/mdq570 Actions

1345P Preliminary safety and activity of CLN-081 in NSCLC with EGFR exon 20 insertion mutations (Ins20)

JOURNAL ARTICLE published September 2020 in Annals of Oncology

Authors: Z. Piotrowska | D. Nguyen | M. Koczywas | N. Tchekmedyian | M.S. Clancy | D. Witter | A. Page | L. Zawel | H.A. Yu

https://doi.org/10.1016/j.annonc.2020.08.1659 Actions

Phase Ib study of safety and tolerability of selinexor in Asian patients with advanced solid cancers

JOURNAL ARTICLE published October 2018 in Annals of Oncology

Authors: V.Y.M. Heong | M.L. Goh | W.P. Yong | R.A. Soo | C.E. Chee | S. Raghav | B.-C. Goh | S.C. Lee | J. Lim | A. Wong | D.S.P. Tan

https://doi.org/10.1093/annonc/mdy279.418 Actions

A comparison of methods currently used in clinical practice to estimate familial breast cancer risks

JOURNAL ARTICLE published April 2000 in Annals of Oncology

Authors: M. Tischkowitz | D. Wheeler | E. France | C. Chapman | A. Lucassen | J. Sampson | P. Harper | M. Krawczak | J. Gray

https://doi.org/10.1023/a:1008396129543 Actions

Prognostic role of changes in neutrophil-to-lymphocyte ratio, tumor-infiltrating lymphocyte with programmed death ligand-1 in triple-negative breast cancer

JOURNAL ARTICLE published October 2018 in Annals of Oncology

Authors: E.K. Joung | J.E. Lee

https://doi.org/10.1093/annonc/mdy271.269 Actions

LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: J. Bourhis | C. Le Tourneau | B. Calderon | L. Martin | C. Sire | Y. Pointreau | J-F. Ramee | A. Coutte | P. Boisselier | M-C. Kaminsky-Forrett | J-P. Delord | F. Clatot | X. Sun | J. Villa | N. Magne | O. Elicin | L. Damstrup | K. Gollmer | P. Crompton | Y. Tao

https://doi.org/10.1016/j.annonc.2022.08.030 Actions

1775P Prevalence of PD-L1 high expression in advanced urothelial carcinoma (aUC): Results from the PREVAIL prospective cohort study

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: P. Grivas | P.K. Agarwal | H. Al-Ahmadie | T. Friedlander | D. Geynisman | I. Hussain | Y. Lotan | A.K. Morgans | M. Tesic-Schnell | J. Meeks

https://doi.org/10.1016/j.annonc.2022.07.1934 Actions

1779TiP Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001)

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: V.S. Koshkin | T.B. Powles | G. Iyer | Y. Loriot | A. Drakaki | I. Duran Martinez | M. De Santis | M. Retz | R.K. Jain | S. Chan | M. Ichimaru | M.D. Galsky

https://doi.org/10.1016/j.annonc.2022.07.1938 Actions

1408P Comparative transcriptomic analyses of 100,691 primary tumors from East Asian (EA) and North American (NA) men with prostate cancer (PCa)

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: M.L.K. Chua | A. Sim | A. Hakansson | E. Ong | K.P. Low | C. Tan | J. Tan | A.S.Y. Lau | J. Tuan | T.W.K. Tan | M.L.C. Wang | J.P.S. Yeong | M.C.S. Tan | L.S. Lee | R. Kanesvaran | K.J. Tay | S. Liu | L.Y. Khor | E. Davicioni

https://doi.org/10.1016/j.annonc.2022.07.1894 Actions

1762P MERINOS: Metastatic non muscle invasive urothelial carcinoma - An observational study

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: M. Haberstich | G. Pignot | J. Rigaud | M. Cancel | D. Maillet | S. Oudard | D. Pouessel | C. Serrate | L. Campedel | C. Dumont | D. Borchiellini | P. Barthelemy | E. Boughalem | E. Colomba | O. Huillard | H.J. Boyle | F. Lefort | F. Constans Schlurmann | F. Audenet | C. Thibault

https://doi.org/10.1016/j.annonc.2022.07.1840 Actions

1398P Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) who received prior androgen deprivation therapy (ADT) and reached low prostate-specific antigen (PSA) levels treated further with enzalutamide (ENZA): Post hoc analyses of ARCHES

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: D.P. Petrylak | A.A. Azad | R.Z. Szmulewitz | T. Iguchi | N.D. Shore | J. Holzbeierlein | B. Alekseev | N.N. El-Chaar | B. Rosbrook | J. Ma | F. Zohren | G.P. Haas | A. Stenzl | A.J. Armstrong

https://doi.org/10.1016/j.annonc.2022.07.1884 Actions

1714P Single-cell RNA sequencing and proteomic analysis reveals dedifferentiation-immunosuppression loop formed by malignant cell and macrophage in intrahepatic cholangiocarcinoma

JOURNAL ARTICLE published September 2022 in Annals of Oncology

Authors: Q. Li | C. Ye | Q. Jiang | R. Chen | W. Wu | F. Yan | X. Shuaishuai | X. Zhang | J. Ruan

https://doi.org/10.1016/j.annonc.2022.07.1792 Actions

2003P Consolidative intrathoracic radiotherapy during maintenance first-line immunotherapy in extensive stage small cell lung cancer (ES-SCLC): A retrospective multicenter analysis of safety and efficacy

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: A. Bruni | F. Bertolini | P. Borghetti | V. Scotti | M. Sepulcri | G. Pasello | N. Giaj-Levra | S. Grisanti | M. Katica | A. Cappelli | P. Garlatti | G. Guaitoli | M. Dominici | F. Lohr

https://doi.org/10.1016/j.annonc.2023.09.1234 Actions

1138P Intralesional administration of L19IL2/L19TNF in difficult-to-treat non-melanoma skin cancer shows a favorable safety profile and preliminary clinical activity

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: L. Flatz | U. Leiter-Stoppke | F. Meraz-Torres | F. Wolfsperger | A. Meiwes | N. Wagner | L. Nadal | E. Puca | G. Elia | A. Covelli | D. Neri | C. Antonio | T.M.S. Amaral

https://doi.org/10.1016/j.annonc.2023.09.2272 Actions

585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: Y. Cao | N. Wang | C. Si | P. Shao | X. Wu | W. Tang | H. Tang | H. Bao | X. Wu | Y. Shao | L. Yang

https://doi.org/10.1016/j.annonc.2023.09.1776 Actions

457P Disparities in receipt of CDK4/6 inhibitors with endocrine therapy as therapy for hormone receptor-positive, HER2-negative metastatic breast cancer in the real-world setting

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: G. Kimmick | A. Pilehvari | W. You | G. Bonilla | R. Anderson

https://doi.org/10.1016/j.annonc.2023.09.633 Actions

1310P Loratadine: A potential game-changer in lung cancer treatment with improved survival outcomes

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: X. Liu | R. Zhong | J. Huang | Z. Chen | H. Xu | L. Lin | Q. Cai | M. He | S. Lao | H. Deng | C.C. Li | J. Li | R. Zeng | Y. Zheng | X. Liu | W. Liang | J. He

https://doi.org/10.1016/j.annonc.2023.09.787 Actions

485P A novel approach to identify subpopulation of CTCs with metastatic potential using sc-RNA-seq

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Research funded by Russian Science Foundation (21-15-00140)

Authors: E. Grigoryeva | L. Tashireva | V.V. Alifanov | M. Zavyalova | M. Menyailo | E.V. Denisov | N.O. Popova | N. Cherdyntseva | V. Perelmuter

https://doi.org/10.1016/j.annonc.2023.09.661 Actions

1991P Safety and effectiveness of surgery or radiotherapy after PD-L1 Inhibitor (TQB-2450) and chemotherapy induction therapy in patients with limited-stage small cell lung cancer: A phase II trial

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: F. Sun | J. Hu | L. Sun | D. Li | L. Zhang | G. Jiang | P. Zhang

https://doi.org/10.1016/j.annonc.2023.09.1222 Actions

1540P Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: Y. Zhang | Y. Yuan | Y. Xu | R. Tian | J. Liao | X. Zeng | Y. Wang | Y. Liu | X. Zhou | F. Peng | L. Zhou | H. Wang | W. Hou | M. Yu | W. Xiu | M. Huang | X. Zhang | Y. Gong | Y. Lu | B. Zou

https://doi.org/10.1016/j.annonc.2023.09.1452 Actions
Feedback: support@crossref.org